Multidrug resistance: can new drugs help chemotherapy score against cancer? - PubMed (original) (raw)
Multidrug resistance: can new drugs help chemotherapy score against cancer?
Bruce Goldman. J Natl Cancer Inst. 2003.
No abstract available
Similar articles
- Monitoring of cellular resistance to cancer chemotherapy.
Krishan A, Arya P. Krishan A, et al. Hematol Oncol Clin North Am. 2002 Apr;16(2):357-72, vi. doi: 10.1016/s0889-8588(01)00016-8. Hematol Oncol Clin North Am. 2002. PMID: 12094476 Review. - Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
Lehne G, De Angelis P, den Boer M, Rugstad HE. Lehne G, et al. Leukemia. 1999 May;13(5):768-78. doi: 10.1038/sj.leu.2401392. Leukemia. 1999. PMID: 10374882 - P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z, Lavasanifar A. Binkhathlan Z, et al. Curr Cancer Drug Targets. 2013 Mar;13(3):326-46. doi: 10.2174/15680096113139990076. Curr Cancer Drug Targets. 2013. PMID: 23369096 Review. - Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
Modok S, Mellor HR, Callaghan R. Modok S, et al. Curr Opin Pharmacol. 2006 Aug;6(4):350-4. doi: 10.1016/j.coph.2006.01.009. Epub 2006 May 11. Curr Opin Pharmacol. 2006. PMID: 16690355 Review. - Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.
Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG, Shih C, Gruber J, Elmquist WF, Dantzig AH. Starling JJ, et al. Adv Enzyme Regul. 1997;37:335-47. doi: 10.1016/s0065-2571(96)00021-0. Adv Enzyme Regul. 1997. PMID: 9381979
Cited by
- Single-nucleotide polymorphisms and mRNA expression of CYP1B1 influence treatment response in triple negative breast cancer patients undergoing chemotherapy.
Abdul Aziz AA, Md Salleh MS, Mohamad I, Krishna Bhavaraju VM, Mazuwin Yahya M, Zakaria AD, Hua Gan S, Ankathil R. Abdul Aziz AA, et al. J Genet. 2018 Dec;97(5):1185-1194. J Genet. 2018. PMID: 30555068 - Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin.
Lin YM, Chen CI, Hsiang YP, Hsu YC, Cheng KC, Chien PH, Pan HL, Lu CC, Chen YJ. Lin YM, et al. Int J Mol Sci. 2018 Jun 14;19(6):1763. doi: 10.3390/ijms19061763. Int J Mol Sci. 2018. PMID: 29899208 Free PMC article. - Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.
Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetunji CO, Michael OS, Sytar O, Polito L, Živković J, Cruz-Martins N, Klimek-Szczykutowicz M, Ekiert H, Choudhary MI, Ayatollahi SA, Tynybekov B, Kobarfard F, Muntean AC, Grozea I, Daştan SD, Butnariu M, Szopa A, Calina D. Sharifi-Rad J, et al. Oxid Med Cell Longev. 2021 Oct 18;2021:3687700. doi: 10.1155/2021/3687700. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34707776 Free PMC article. Review. - Efflux transporters: newly appreciated roles in protection against pollutants.
Epel D, Luckenbach T, Stevenson CN, Macmanus-Spencer LA, Hamdoun A, Smital T. Epel D, et al. Environ Sci Technol. 2008 Jun 1;42(11):3914-20. doi: 10.1021/es087187v. Environ Sci Technol. 2008. PMID: 18589945 Free PMC article. No abstract available. - Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
Rijavec M, Silar M, Triller N, Kern I, Cegovnik U, Košnik M, Korošec P. Rijavec M, et al. Pathol Oncol Res. 2011 Sep;17(3):691-6. doi: 10.1007/s12253-011-9370-2. Epub 2011 Apr 1. Pathol Oncol Res. 2011. PMID: 21455636
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources